Hj. Meyerson et al., FUNCTIONAL DISSOCIATION OF CD8-ALPHA-S IG HOMOLOG AND CONNECTING PEPTIDE DOMAINS, The Journal of immunology, 156(2), 1996, pp. 574-584
The contribution of the CD8 alpha . IgV homologue domain to class I MH
C binding was evaluated using a series of chimeric human CD8 alpha:Fs
polypeptides incorporating alternative CD8 alpha extracellular domain
components, Using a nonisotopic cellfree physical binding assay, those
Fe chimeras encompassing the CD8 alpha:IgV homologue domain only (dis
sociated from the 48-amino acid CD8 alpha connecting peptide) were sho
wn to retain the capacity of the complete CD8 alpha extracellular doma
in to bind to a recombinant soluble class I MHC alpha(3) domain unit o
r to intact class I MHC. The specificity of the CD8 alpha:class I MHC
alpha(3) domain interaction was verified by mAb and soluble polypeptid
e blocking experiments, Furthermore, co-precipitation of an Fc chimera
incorporating only the CD8 alpha . IgV homologue domain and a recombi
nant soluble class I MHC alpha(3) domain unit was accomplished, In add
ition, a glycosylphosphatidylinositol (GPI)-modified variant of the CD
8 alpha . IgV homologue domain was generated via chimerization with th
e GPI signal sequence from decay-accelerating factor, Gal anchorage fo
r this truncated CD8 alpha polypeptide was verified, and its capacity
to promote intercellular adhesion through class I MHC binding was show
n in a cell:cell binding assay, The findings indicate that the CD8 alp
ha . IgV homologue domain acts as an independent structural unit when
dissociated from the CD8 alpha connecting peptide, and in so doing ret
ains class I MHC binding capacity. This further establishes the princi
ple that Ig superfamily domains from receptor:counter-receptor pairs c
an interact with each other as isolated units, providing an experiment
al path for tailoring therapeutically useful IgSF protein derivatives.